Sanofi believes in Novavax's vaccine strengths...Novavax (NVAX 11.63%) and Moderna (MRNA 2.81%) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% increase for Moderna. Investors were betting on the companies' coronavirus vaccine candidates and their ability to bring in billions of dollars in revenue.Moderna fared well, dominating the vaccine market along with big pharma ...